NDC 59651-546 – Dasatinib
Dasatinib 100 mg/1 · Tablet · Oral
Product NDC59651-546
Product details
- Brand name
- Dasatinib
- Generic name
- Dasatinib
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA216547
- Marketed since
- April 22, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Dasatinib 100 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 59651-546-15 | 1 BLISTER PACK in 1 CARTON (59651-546-15) / 15 TABLET in 1 BLISTER PACK | Apr 22, 2025 |
| 59651-546-30 | 30 TABLET in 1 BOTTLE (59651-546-30) | Apr 22, 2025 |
Other Dasatinib products
- 59651-542 Dasatinib 20 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-543 Dasatinib 50 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-544 Dasatinib 70 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-545 Dasatinib 80 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-547 Dasatinib 140 mg/1 · Tablet · Aurobindo Pharma Limited
- 70748-212 Dasatinib 100 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-208 Dasatinib 20 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-213 Dasatinib 140 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-209 Dasatinib 50 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-210 Dasatinib 70 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-211 Dasatinib 80 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 72205-319 Dasatinib 20 mg/1 · Tablet · Novadoz Pharmaceuticals LLC